October 2018 - Volume 28 - Issue 5
pp: 371-487

Nivolumab monotherapy or in combination with ipilimumab for metastatic melanoma: systematic review and meta-analysis of randomized-controlled trials

Menshawy, Amr; Eltonob, Abdelrahman A.; Barkat, Sarah A.; More

Melanoma Research. 28(5):371-379, October 2018.


Basic science


Translational research


Compromised vitamin D receptor signalling in malignant melanoma is associated with tumour progression and mitogen-activated protein kinase activity

Hutchinson, Peter E.; Halsall, John A.; Popovici, Silvia; More

Melanoma Research. 28(5):410-422, October 2018.

Clinical research


High baseline neutrophil-to-lymphocyte ratio predicts worse outcome in patients with metastatic BRAF-positive melanoma treated with BRAF and MEK inhibitors

Teterycz, Pawel; Jagodzinska-Mucha, Paulina; Cybulska-Stopa, Bozena; More

Melanoma Research. 28(5):435-441, October 2018.

Epidemiology of melanoma



Early onset of diffuse melanosis cutis under pembrolizumab therapy illustrates the limitations of anti-PD-1 checkpoint inhibitors

Thiem, Alexander; Schummer, Patrick; Ueberschaar, Simon; More

Melanoma Research. 28(5):465-468, October 2018.